Catalyst Wire Dossier Catalyst Wire Dossier

Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2

treprostinil palmitil inhalation powder · Insmed Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy Participants [Phase 1]

See pricing